Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06400992
Other study ID # APHP230143
Secondary ID 2023-A02351-44
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 2024
Est. completion date December 2024

Study information

Verified date April 2024
Source Assistance Publique - Hôpitaux de Paris
Contact Nathalie LOUNDON, MD, PhD
Phone +33 1 71 39 67 82
Email natalie.loundon@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The hypothesis of this research is that the AS Target setting provides the best estimate of the settings required to optimize listening in noise. As such, it is expected that speech in noise performance will be best in the AS Target condition, followed by the AS Clinic condition, and the Omni condition will be the least favourable for speech in noise performance


Description:

The ability to hear speech in noise is particularly important for children, as they are often in complex listening situations like classrooms or playgrounds. In children with hearing loss, the ability to understand speech in noise is further degraded not only by decreased audibility of speech sounds, but also additionally by the distortion spectral and temporal processing cues, and reduced binaural processing abilities. Cochlear implant manufacturers have introduced a number of technologies designed to improve speech recognition in background noise. Sound processing algorithms use a variety of strategies to facilitate listening in noise, and research has shown that these advances do lead to improved performance. AutoSense Sky OS 3.0 (AutoSense Sky OS, AS) is an automatic auditory scene classification system specifically designed for children's typical listening situations, like classrooms and playgrounds. This technology is available in the new Sky CI M90 (Sky CI), which is the latest generation of sound processor (SP) from Advanced Bionics, designed for children. This algorithm is also available in the Sky Link M90 hearing aid (Sky Link). This means that bimodal patients, using one Sky Link and one Sky CI can benefit from AutoSense Sky OS in addition to children with two Sky CI. The combination of the two hearing devices (HD) tested in this research, whether it be two Sky CI or one Sky CI and one Sky Link, will be referred to as the Sky Hearing System (Sky HS). As usual in standard care, children with Sky HS can have their hearing system programmed in three ways (at the discretion of the clinician): 1. Omnidirectional mode, in which the AutoSense Sky OS is deactivated and no modifications are made by the clinician (no sound treatment) 2. AS Target, in which the AutoSense Sky OS is active and programmed with the parameters suggested by the programming software (Target) and no modifications are made by the clinician 3. AS clinic, in which the AutoSense Sky OS is active, and settings have been modified by the clinician (mixed setting). The goal of this research is to compare speech in noise perception in each of those three possible programming conditions used in the standard care. The hypothesis of this research is that the AS Target setting provides the best estimate of the settings required to optimize listening in noise. As such, it is expected that speech in noise performance will be best in the AS Target condition


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date December 2024
Est. primary completion date June 2024
Accepts healthy volunteers No
Gender All
Age group 6 Years to 16 Years
Eligibility Inclusion Criteria: - Be between 6 and 16 years of age at the time of inclusion - Use spoken French as their primary mode of communication - Ability to perform the Simplified French Matrix test in Noise - Bimodal group: use the Sky CI processor or be eligible for a Sky CI processor upgrade on one side and use a contralateral hearing aid - Bilaterally implanted group: use two Sky CI processors or be eligible for an upgrade to two Sky CI processors - Obtain signed consent from legal guardian(s) - Be enrolled in a health insurance plan or eligible for coverage Exclusion Criteria: - Severe neurological pathology identified prior to inclusion identified by MRI + /- neuro-pediatric workup - Severe cognitive, psychiatric, or developmental disabilities identified prior to inclusion - Family does not understand French

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cochlear implant processor Sky CITM M90 (CI-5295)
The Sky CI available to included patients (no procedures added) offers the AutoSense Sky OS technology with the three following programming conditions possible. This three condition are fitting and evaluated in noise 6 months after inclusion: Omnidirectional mode : no sound treatment AS Target : Autosense is active and no modifications are made by clinician AS Clinique : Autosense is active and modified by the clinician
Hearing Aid, including sound processor Phonak: Sky Link M90
The device is fitting and programmed for home especially for the purpose research at inclusion. The Clinical map parameters will be verified according to clinical routine. The Sky Link offers the AutoSense Sky OS technology with the three following programming conditions possible. This three condition are fitting and evaluated in noise 6 months after inclusion: Omnidirectional mode : no sound treatment AS Target : Autosense is active and no modifications are made by clinician AS Clinique : Autosense is active and modified by the clinician
Diagnostic Test:
French simplified matrix test (FraSimat)
The FraSimat speech in noise test will be tested, 6 months before inclusion in the three different fitting configurations: omni, AS clinic, AS Target. The speech will be presented from the front, noise from 180°. Noise will be presented at a fixed level of 65 dB SPL while the speech signal will be adapted to find the 50% speech reception threshold (SRT).
Behavioral:
Audiologist Fitting Questionnaire
After the fitting of Hearing Aid at inclusion, the audiologist will complete a questionnaire describing the fitting and justifying fitting decisions and will collect the demographic information
Patient Satisfaction Questionnaire
The patient will be giving a Patient satisfaction Questionnaire, with questions regarding device and accessory use. The audiologist will go over the instructions for filling out the questionnaire at inclusion. Patients will be asked to complete the questionnaire and return it at the next visit, 6 months after inclusion.
AutoSens Feedback Discussion Form
6 months after inclusion and fitting, the audiologist discusses the use of AS clinic with the subject and completes the AS questionnaire (questionnaire on the experience of using the processor in different listening situations).

Locations

Country Name City State
France Audiophonology Unit of the Ear, Nose and Throat (ENT) Department ("Oto-rhino-laryngologie (ORL) et chirurgie cervico-faciale") at the Necker-Enfants Malades hospital (AP-HP). Paris

Sponsors (2)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Advanced Bionics AG

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Speech in noise perception (FraSimat) Omni vs AS Target Difference in the FraSimat score obtained with the Sky HS programmed in Omni versus the score obtained in AS Target 6 months
Secondary Speech in noise perception (FraSimat) AS Clinic vs Omni Difference in the FraSimat score obtained with the Sky HS programmed in AS Clinic versus the score obtained in Omni 6 months
Secondary Speech in noise perception (FraSimat) AS clinic vs AS Target Difference in the FraSimat score obtained with the Sky HS programmed in AS Clinic versus the score obtained in AS Target 6 months
Secondary Patient satisfaction - device A patient questionnaire will be used to determine patient satisfaction with the devices 6 months
Secondary Patient satisfaction -listening With the help of the audiologist, patients will discuss and rate listening quality in different listening situations. 6 months
Secondary Audiologist programming modifications An audiologist questionnaire will be used to determine the programming modifications and decisions made by the audiologist for each individual patient 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04696835 - fNIRS in Pediatric Hearing Aids N/A
Completed NCT03662256 - Reducing Childhood Hearing Loss in Rural Alaska Through a Preschool Screening and Referral Process Using Mobile Health and Telemedicine N/A
Completed NCT04602780 - Evaluating the Revised WORQ in CI Users
Completed NCT03723161 - Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT03428841 - Audiovisual Assessment After Dural Puncture During Epidural Placement in Obstetric Patients N/A
Completed NCT04559282 - Home Test of New Sound Processor N/A
Enrolling by invitation NCT03345654 - Individually-guided Hearing Aid Fitting
Completed NCT06016335 - MRI-based Synthetic CT Images of the Head and Neck N/A
Completed NCT05165121 - Comparison of Hearing Aid Fitting Outcomes Between Self-fit and Professional Fit for MDHearing Smart Hearing Aids N/A
Recruiting NCT05533840 - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Terminated NCT02294812 - Effects of Cognitive Training on Speech Perception N/A
Completed NCT04622059 - AUditive Direct In-utero Observation (AUDIO): Prenatal Testing of Congenital Hypoacusis N/A
Recruiting NCT02558478 - Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing N/A
Withdrawn NCT02740322 - Validating the Hum Test N/A
Completed NCT01963104 - Community-Based Kiosks for Hearing Screening and Education N/A
Completed NCT01857661 - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial N/A
Completed NCT01892007 - Evaluation of Cogmed Working Memory Training for Adult Hearing Aid Users N/A
Withdrawn NCT01223638 - The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism N/A